Patients will successively experience metabolic disorders such as decreased appetite, skeletal muscle proteolysis, increased gluconeogenesis, and insulin resistance in a short period of time, and the amount of protein consumption increases dramatically in a short period of time, making it difficult to maintain the basic energy needs of the body because the patient's own nutritional level decreases rapidly [11]. The gene discussed is INS; the disease is metabolic disease.